Health Care & Life Sciences » Biotechnology | Rich Pharmaceuticals Inc.

Rich Pharmaceuticals Inc.

Rich Pharmaceuticals Inc.
Stock Exchange Other OTC
Market Cap
$188.39 K
Shares Outstanding
1.88 B
Public Float
1.87 B


145 South Fairfax Avenue
Los Angeles California 90036
United States
Employees -
Updated 07/08/2019
Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin's lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA.


View All

Carol A. Salvadore
Ben Chang
Chairman, President, CEO, CFO & Secretary